Topera, Inc., a venture-backed medical device company, has developed a novel 3D analysis and mapping system to assist electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias. The Topera 3D Mapping System, which consists of the FDA-cleared and CE-Marked RhythmView™ Workstation and FIRMap™ diagnostic catheter, is designed to improve patient outcomes by enabling electrophysiologists to view a dynamic representation of the electrical activity of the heart, supporting the diagnosis of and treatment planning for a variety of arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia. With its disruptive technology, extensive intellectual property, accomplished medical device management team and top-tier investor base, Topera is poised to help transform the standard of care for patients with heart rhythm disorders. Topera is currently hiring for positions in its Menlo Park, CA and St. Louis, MO offices, as well as for field-based positions throughout the US and Europe. To learn more, please visit our website at www.toperamedical.com.